Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Weintraub

Showing results (41-50 of 412) with videos related to

Pageof 42
Sort By:
Neurology|May 21, 2015
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyDaniel Weintraub, Kimberly Papay, Sharon X Xie
JAMA Neurology|July 12, 2016
The Danger of Not Treating Parkinson Disease Psychosis-ReplyDaniel Weintraub, Helen C Kales, Connie Marras
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2015
Reply to letter to the editor 'Independent application of MoCA/MMSE conversion' by Armstrong et alInger van Steenoven, Dag Aarsland, Daniel Weintraub
JAMA Neurology|November 25, 2014
Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerabilityKara M Smith, Eli Eyal, Daniel Weintraub, et al.
The American Journal of Managed Care|April 18, 2008
Parkinson's disease--Part 2: Treatment of motor symptomsDaniel Weintraub, Cynthia L Comella, Stacy Horn
The Lancet. Neurology|March 23, 2017
Cognitive decline before diagnosis of Parkinson's disease - Authors' replyAnette Schrag, Daniel Weintraub, Jonathan M Schott
Nature Clinical Practice. Neurology|November 30, 2007
Drug Insight: impulse control disorders and dopamine therapies in Parkinson's diseaseMarc N Potenza, Valerie Voon, Daniel Weintraub
The American Journal of Managed Care|April 18, 2008
Parkinson's disease--Part 3: Neuropsychiatric symptomsDaniel Weintraub, Cynthia L Comella, Stacy Horn
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 2007
Effect of age on geriatric depression scale performance in Parkinson's diseaseDaniel Weintraub, Kirsten Saboe, Matthew B Stern
Movement Disorders : Official Journal of the Movement Disorder Society|April 24, 2014
Psychiatric issues in cognitive impairmentDag Aarsland, John-Paul Taylor, Daniel Weintraub
Pageof 42

Showing results (41-50 of 412) with videos related to

Sort By:
Pageof 42
Neurology|May 21, 2015
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyDaniel Weintraub, Kimberly Papay, Sharon X Xie
JAMA Neurology|July 12, 2016
The Danger of Not Treating Parkinson Disease Psychosis-ReplyDaniel Weintraub, Helen C Kales, Connie Marras
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2015
Reply to letter to the editor 'Independent application of MoCA/MMSE conversion' by Armstrong et alInger van Steenoven, Dag Aarsland, Daniel Weintraub
JAMA Neurology|November 25, 2014
Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerabilityKara M Smith, Eli Eyal, Daniel Weintraub, et al.
The American Journal of Managed Care|April 18, 2008
Parkinson's disease--Part 2: Treatment of motor symptomsDaniel Weintraub, Cynthia L Comella, Stacy Horn
The Lancet. Neurology|March 23, 2017
Cognitive decline before diagnosis of Parkinson's disease - Authors' replyAnette Schrag, Daniel Weintraub, Jonathan M Schott
Nature Clinical Practice. Neurology|November 30, 2007
Drug Insight: impulse control disorders and dopamine therapies in Parkinson's diseaseMarc N Potenza, Valerie Voon, Daniel Weintraub
The American Journal of Managed Care|April 18, 2008
Parkinson's disease--Part 3: Neuropsychiatric symptomsDaniel Weintraub, Cynthia L Comella, Stacy Horn
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 2007
Effect of age on geriatric depression scale performance in Parkinson's diseaseDaniel Weintraub, Kirsten Saboe, Matthew B Stern
Movement Disorders : Official Journal of the Movement Disorder Society|April 24, 2014
Psychiatric issues in cognitive impairmentDag Aarsland, John-Paul Taylor, Daniel Weintraub
Pageof 42